檢索結果 - Shaoying Li
- Showing 1 - 20 results of 32
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor ou... 由 Shaoying Li, Pei Lin, Luis Fayad, Patrick A. Lennon, Roberto N. Miranda, C. Cameron Yin, E. Lin, L. Jeffrey Medeiros
出版 2011Artigo -
8
-
9
Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid Leukemia 由 Qing Wei, Shimin Hu, Sanam Loghavi, Gökçe Törüner, Farhad Ravandi, Zhenya Tang, Shaoying Li, Jie Xu, Naval Daver, L. Jeffrey Medeiros, Guilin Tang
出版 2025Artigo -
10
-
11
MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas 由 Wenting Huang, L. Jeffrey Medeiros, Pei Lin, Wei Wang, Guilin Tang, Joseph D. Khoury, Sergej Konoplev, C. Cameron Yin, Jie Xu, Yasuhiro Oki, Shaoying Li
出版 2018Artigo -
12
Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual... 由 Wei Wang, Joseph D. Khoury, Roberto N. Miranda, Jeffrey L. Jorgensen, Jie Xu, Sanam Loghavi, Shaoying Li, Naveen Pemmaraju, Than Nguyen, L. Jeffrey Medeiros, Sa A. Wang
出版 2020Artigo -
13
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cel... 由 Xuan J. Wang, L. Jeffrey Medeiros, Carlos E. Bueso‐Ramos, Guilin Tang, Sa Wang, Yasuhiro Oki, Parth Desai, Joseph D. Khoury, Roberto N. Miranda, Zhenya Tang, Nishitha Reddy, Shaoying Li
出版 2016Artigo -
14
PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma 由 Jing Shen, Shaoying Li, L. Jeffrey Medeiros, Pei Lin, Sa A. Wang, Guilin Tang, C. Cameron Yin, M. James You, Joseph D. Khoury, Swaminathan P. Iyer, Roberto N. Miranda, Jie Xu
出版 2019Artigo -
15
<i>DUSP22</i> rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma 由 Lianqun Qiu, Guilin Tang, Shaoying Li, Francisco Vega, Pei Lin, Sa A. Wang, Wei Wang, Swaminathan P. Iyer, Luis Malpica, Roberto N. Miranda, Sergej Konoplev, Zhenya Tang, Hong Fang, L. Jeffrey Medeiros, Jie Xu
出版 2022Artigo -
16
Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera 由 Guilin Tang, Juliana Elisa Hidalgo Lopez, Sa A. Wang, Shimin Hu, Junsheng Ma, Sherry Pierce, Wenli Zuo, Adrián A. Carballo‐Zarate, C. Cameron Yin, Zhenya Tang, Shaoying Li, L. Jeffrey Medeiros, Srđan Verstovšek, Carlos E. Bueso‐Ramos
出版 2017Artigo -
17
CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course 由 Zhihong Hu, Yi Sun, Ellen Schlette, Guilin Tang, Shaoying Li, Jie Xu, C. Cameron Yin, Ken H. Young, Keyur P. Patel, Roberto N. Miranda, Maitrayee Goswami, Michael Wang, Jeffrey L. Jorgensen, L. Jeffrey Medeiros, Sa A. Wang
出版 2017Artigo -
18
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma 由 Andres Quesada, L. Jeffrey Medeiros, Parth Desai, Pei Lin, Jason R. Westin, Huda M Hawsawi, Peng Wei, Guilin Tang, Adam C. Seegmiller, Nishitha Reddy, C. Cameron Yin, Wei Wang, Jie Xu, Roberto N. Miranda, Zhuang Zuo, Shaoying Li
出版 2017Artigo -
19
Pure erythroid leukemia is characterized by biallelic <i>TP53</i> inactivation and abnormal p53 expression patterns in <i>de novo</i> and secondary cases 由 Hong Fang, Sa A. Wang, Joseph D. Khoury, Siba El Hussein, Do H. Kim, Mehrnoosh Tashakori, Zhenya Tang, Shaoying Li, Zhìhóng Hú, Fatima Zahra Jelloul, Keyur P. Patel, Timothy J. McDonnell, Tapan M. Kadia, L. Jeffrey Medeiros, Wei Wang
出版 2022Artigo -
20
Long‐term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib 由 Preetesh Jain, Rashmi Kanagal‐Shamanna, Shaojun Zhang, Makhdum Ahmed, Ahmad Ghorab, Liang Zhang, Chi Young Ok, Shaoying Li, Frederick Hagemeister, Dongfeng Zeng, Tiejun Gong, Wendy Chen, Maria Badillo, Krystle Nomie, Luis Fayad, Leonard Jeffrey Medeiros, Sattva S. Neelapu, Nathan Fowler, Jorge Romaguera, Richard E. Champlin, Linghua Wang, Michael Wang
出版 2018Artigo
相關主題
Medicine
Internal medicine
Biology
Lymphoma
Gene
Cancer research
Immunology
Oncology
Pathology
Biochemistry
Genetics
Diffuse large B-cell lymphoma
Leukemia
Cancer
Mantle cell lymphoma
Antibody
B cell
Gastroenterology
Germinal center
Rituximab
Cell biology
Chromosome
Chronic lymphocytic leukemia
BCL6
Bone marrow
Chemistry
Adenocarcinoma
B-cell lymphoma
Chemotherapy
Cytogenetics